Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01896960Phase 2Unknown
Phase 2, randomised, single-blind trial of bupivacaine in hypotension, sponsored by McGill University Health Centre. Primary endpoint: Sitting time to avoid hypotension at 1 hour. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01896960.